PGRMC1 and hepatocellular carcinoma: We also performed a Pgrmc1 KO study using a murine model of HCC using diethylnitrosamine (DEN) administration and show that the loss of Pgrmc1 suppresses the development of HCC and extends the HCC-related survival period.